Flexible statistics and programming support for biotech teams across Phase I–IV studies.
Combining scientific rigor and deep therapeutic knowledge, we help you turn complex data into clear, defensible evidence for faster, better-informed decisions and a more confident path towards regulatory approval.
We tailor our statistical expertise to meet your needs, whether for a single study or an entire development program:
Ensure clean, accurate, and submission-ready datasets through rigorous processes and expert oversight.
Transform study data into compliant, high-quality outputs for confident decision-making and regulatory success.
Generate robust evidence to demonstrate product value, support market access, and inform clinical strategy.
Seamless compliance, efficiency, and innovation through expert governance, advanced automation, real-time visualization, and AI-powered solutions.
Decades of combined experience delivering high-quality statistical design and analysis for successful regulatory submissions, backed by expert statisticians across Phase I–IV trials and proven regulatory submission experience.
Easy-to-work-with, collaborative, responsive teams who act as a trusted extension of yours, maintaining clear, honest communication throughout the project and a quality focus at all times.
Support from protocol design, sample size calculations, and randomization planning through to full study analysis and reporting, delivering high-quality, audit-ready outputs at every stage.
Flexibility to ramp resources up or down to meet changing timelines, study demands, and budgets without compromising quality, supported by a flexible project-based support model.
Proven success across all phases and a wide range of therapeutic areas, applying best practices tailored to each indication.
Services shaped to your study’s unique requirements, ensuring the right expertise and processes are in place at every stage.
